Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
暂无分享,去创建一个
Mark Oppe | Nan Luo | Benjamin M Craig | Juan M Ramos-Goñi | Jose Luis Pinto-Prades | Oliver Rivero-Arias | Yolanda Ramallo-Fariña | O. Rivero-Arias | N. Luo | Benjamin Matthew Craig | J. Pinto-Prades | M. Oppe | Y. Ramallo-Fariña | J. Ramos-Goñi
[1] M. Roca,et al. The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010. , 2013, European journal of public health.
[2] M. Roca,et al. Economic crisis and mental health in Spain , 2013, The Lancet.
[3] Nan Luo,et al. The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework , 2013, The European Journal of Health Economics.
[4] P. Kind,et al. A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[5] G W Torrance,et al. A utility maximization model for evaluation of health care programs. , 1972, Health services research.
[6] Mark Oppe,et al. Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach , 2014, Medical care.
[7] J. Brazier,et al. A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] Mark Oppe,et al. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[9] W. Brouwer,et al. Lead time TTO: leading to better health state valuations? , 2013, Health economics.
[10] Mark Oppe,et al. Learning and satisficing: an analysis of sequence effects in health valuation. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] Pravin K. Trivedi,et al. Microeconometrics Using Stata , 2009 .
[12] J. Louviere,et al. Conducting Discrete Choice Experiments to Inform Healthcare Decision Making , 2012, PharmacoEconomics.
[13] Mark Oppe,et al. Introducing the composite time trade-off: a test of feasibility and face validity , 2013, The European Journal of Health Economics.
[14] Juan Manuel Ramos-Goñi,et al. Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong , 2017, The Patient - Patient-Centered Outcomes Research.
[15] Angela Robinson,et al. Exploring challenges to TTO utilities: valuing states worse than dead. , 2006, Health economics.
[16] M. San Sebastiån,et al. How are the employed and unemployed affected by the economic crisis in Spain? Educational inequalities, life conditions and mental health in a context of high unemployment , 2016, BMC Public Health.
[17] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[18] Mark Oppe,et al. EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes , 2016, PharmacoEconomics.
[19] M. Suhrcke,et al. The evolution of mental health in Spain during the economic crisis. , 2014, European journal of public health.
[20] Juan M Ramos-Goñi,et al. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[21] T. Kohlmann,et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[22] Mark Oppe,et al. Lead versus lag-time trade-off variants: does it make any difference? , 2013, The European Journal of Health Economics.
[23] Mark Oppe,et al. Quality Control Process for EQ-5D-5L Valuation Studies. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[24] Jan Passchier,et al. The Indonesian EQ-5D-5L Value Set , 2017, PharmacoEconomics.